COVID-19患者心血管并发症及预后

Q4 Medicine

Revista Espanola de Cardiologia Suplementos Pub Date : 2020-01-01 DOI:10.1016/S1131-3587(20)30029-7

Alberto Cordero , David Escribano , Vicente Bertomeu-González

{"title":"COVID-19患者心血管并发症及预后","authors":"Alberto Cordero , David Escribano , Vicente Bertomeu-González","doi":"10.1016/S1131-3587(20)30029-7","DOIUrl":null,"url":null,"abstract":"<div><p>Although the risk of death is generally low in patients with SARS-CoV-2 infection, 15-20% of those infected experience lung disease with a varying degree of systemic involvement, which is referred to as coronavirus disease 2019 (COVID-19) and is associated with higher mortality. From the first patient series reported, myocardial damage has been observed in many individuals with COVID-19 and has been linked to an increased risk of death. This review summarizes current knowledge about cardiovascular disease and prognosis in patients with COVID-19, with a particular emphasis on different cardiovascular conditions and on the treatment of hospitalized patients.</p></div>","PeriodicalId":34926,"journal":{"name":"Revista Espanola de Cardiologia Suplementos","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1131-3587(20)30029-7","citationCount":"2","resultStr":"{\"title\":\"Complicaciones cardiovasculares y pronóstico en pacientes con COVID-19\",\"authors\":\"Alberto Cordero , David Escribano , Vicente Bertomeu-González\",\"doi\":\"10.1016/S1131-3587(20)30029-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Although the risk of death is generally low in patients with SARS-CoV-2 infection, 15-20% of those infected experience lung disease with a varying degree of systemic involvement, which is referred to as coronavirus disease 2019 (COVID-19) and is associated with higher mortality. From the first patient series reported, myocardial damage has been observed in many individuals with COVID-19 and has been linked to an increased risk of death. This review summarizes current knowledge about cardiovascular disease and prognosis in patients with COVID-19, with a particular emphasis on different cardiovascular conditions and on the treatment of hospitalized patients.</p></div>\",\"PeriodicalId\":34926,\"journal\":{\"name\":\"Revista Espanola de Cardiologia Suplementos\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S1131-3587(20)30029-7\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Espanola de Cardiologia Suplementos\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1131358720300297\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola de Cardiologia Suplementos","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1131358720300297","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 2

摘要

尽管SARS-CoV-2感染患者的死亡风险普遍较低，但15-20%的感染者会出现不同程度的全身累及的肺部疾病，这被称为2019年冠状病毒病(COVID-19)，并与较高的死亡率相关。从报告的第一个患者系列来看，在许多COVID-19患者中观察到心肌损伤，并与死亡风险增加有关。本文综述了目前关于COVID-19患者心血管疾病和预后的知识，特别强调了不同心血管疾病和住院患者的治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Complicaciones cardiovasculares y pronóstico en pacientes con COVID-19

Although the risk of death is generally low in patients with SARS-CoV-2 infection, 15-20% of those infected experience lung disease with a varying degree of systemic involvement, which is referred to as coronavirus disease 2019 (COVID-19) and is associated with higher mortality. From the first patient series reported, myocardial damage has been observed in many individuals with COVID-19 and has been linked to an increased risk of death. This review summarizes current knowledge about cardiovascular disease and prognosis in patients with COVID-19, with a particular emphasis on different cardiovascular conditions and on the treatment of hospitalized patients.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Revista Espanola de Cardiologia Suplementos Medicine-Cardiology and Cardiovascular Medicine

CiteScore

1.20

自引率

0.00%

发文量

期刊介绍： Revista Española de Cardiología, is an international scientific journal dealing with cardiovascular medicine. Revista Española de Cardiología, the official publication of the Spanish Society of Cardiology, publishes research articles related to cardiovascular diseases. Articles are published in Spanish for the paper edition and in both Spanish and English in the electronic edition, which is available on the Internet. Regular sections include original articles reporting clinical or basic research, brief reports, review articles, editorials and letters to the Editor.